Systemic Immune-Inflammation Index is Associated with Cerebral Small Vessel Disease Burden and Cognitive Impairment

Objective This study sought to explore the associations of the systemic immune-inflammation index (SII) with total cerebral small vessel disease (CSVD) burden and cognitive impairment. Methods We enrolled 201 patients in the retrospective study with complete clinical and laboratory data. The SII was calculated as platelet count × neutrophil count/lymphocyte count. Cognitive function was evaluated by the Mini-Mental State Examination (MMSE). Total CSVD burden was assessed based on magnetic resonance imaging. We performed logistic regression models, Spearman correlation, and mediation analysis to evaluate the associations of SII with CSVD burden and cognitive impairment. Results After adjustment for confounding factors in the multivariate binary logistic regression model, elevated SII (odds ratio [OR], 3.263; 95% confidence interval [CI], 1.577–6.752; P = 0.001) or severe CSVD burden (OR, 2.794; 95% CI, 1.342–5.817; P = 0.006) was significantly associated with the risk of cognitive impairment. Correlation analyses revealed that SII levels were negatively associated with MMSE scores (rs = −0.391, P < 0.001), and positively associated with the total CSVD burden score (rs = 0.361, P < 0.001). Moreover, SII was significantly related to the severity of the CSVD burden (OR, 2.674; 95% CI, 1.359–5.263; P = 0.004). The multivariable-adjusted odds ratios (95% CI) in highest tertile versus lowest tertile of SII were 8.947 (3.315–24.145) for cognitive impairment and 4.945 (2.063–11.854) for severe CSVD burden, respectively. The effect of higher SII on cognitive impairment development was partly mediated by severe CSVD burden. Conclusion Elevated SII is associated with severe CSVD burden and cognitive impairment. The mediating role of severe CSVD burden suggests that higher SII may contribute to cognitive impairment through aggravating CSVD burden.

[1]  Yushun Zhang,et al.  Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease , 2022, Frontiers in Cardiovascular Medicine.

[2]  Yilong Wang,et al.  Correlation of the systemic immune-inflammation index with short- and long-term prognosis after acute ischemic stroke , 2022, Aging.

[3]  Mengsi Liu,et al.  Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis , 2022, Frontiers in Cardiovascular Medicine.

[4]  Xuan Wang,et al.  Association of Dietary Inflammatory Potential with Blood Inflammation: The Prospective Markers on Mild Cognitive Impairment , 2022, Nutrients.

[5]  Hao Li,et al.  Association of inflammatory markers with cerebral small vessel disease in community-based population , 2022, Journal of Neuroinflammation.

[6]  Han-Yeong Jeong,et al.  Systemic immune-inflammation index is associated with white matter hyperintensity volume , 2022, Scientific Reports.

[7]  Wenbin Lu,et al.  The Association Between Systemic Immune-Inflammation Index and Postoperative Cognitive Decline in Elderly Patients , 2022, Clinical interventions in aging.

[8]  Liangren Liu,et al.  The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer , 2022, Frontiers in Immunology.

[9]  O. Soehnlein,et al.  Neutrophils in chronic inflammatory diseases , 2022, Cellular & Molecular Immunology.

[10]  T. Arumugam,et al.  Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment , 2022, Theranostics.

[11]  S. Greenberg Vascular Contributions to Brain Health: Cross-Cutting Themes. , 2022, Stroke.

[12]  R. Marioni,et al.  DNA Methylation and Protein Markers of Chronic Inflammation and Their Associations With Brain and Cognitive Aging , 2021, Neurology.

[13]  Wenli Hu,et al.  Higher Total Cerebral Small Vessel Disease Burden Was Associated With Mild Cognitive Impairment and Overall Cognitive Dysfunction: A Propensity Score-Matched Case–Control Study , 2021, Frontiers in Aging Neuroscience.

[14]  Xuchu Wang,et al.  Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[15]  L. Pantoni,et al.  Association of Bone Mineral Density to Cerebral Small Vessel Disease Burden , 2021, Neurology.

[16]  J. Jia,et al.  Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. , 2020, The Lancet. Public health.

[17]  Angela C. C. Jochems,et al.  Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta‐analysis , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[18]  Joseph C. Sun,et al.  Clonal expansion of innate and adaptive lymphocytes , 2020, Nature Reviews Immunology.

[19]  M. Dichgans,et al.  Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.

[20]  J. O'Brien,et al.  Inflammation and cerebral small vessel disease: A systematic review , 2019, Ageing Research Reviews.

[21]  B. Stricker,et al.  The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study , 2019, International journal of cancer.

[22]  M. Hauptmann,et al.  Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study , 2018, Breast cancer research : BCR.

[23]  A. Hofman,et al.  Cerebral small vessel disease and the risk of dementia: A systematic review and meta-analysis of population-based evidence , 2018, Alzheimer's & Dementia.

[24]  Mayur B. Patel,et al.  Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability , 2018, Intensive Care Medicine.

[25]  H. Markus,et al.  Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease , 2017, Neurology.

[26]  Hammad Naveed,et al.  The effect of systemic inflammation on human brain barrier function , 2017, Brain, Behavior, and Immunity.

[27]  I. Galea,et al.  The blood-brain barrier in systemic inflammation , 2017, Brain, Behavior, and Immunity.

[28]  J. Jia,et al.  Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study. , 2016, Journal of Alzheimer's disease : JAD.

[29]  J. Quevedo,et al.  The role of microglia activation in the development of sepsis-induced long-term cognitive impairment , 2015, Brain, Behavior, and Immunity.

[30]  Joanna M. Wardlaw,et al.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.

[31]  W. Guo,et al.  Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma , 2014, Clinical Cancer Research.

[32]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[33]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[34]  Karen J. Ferguson,et al.  Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.

[35]  D. Germolec,et al.  Markers of inflammation. , 2010, Methods in molecular biology.

[36]  D. Werring,et al.  The Microbleed Anatomical Rating Scale (MARS) , 2009, Neurology.

[37]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.